Pharvaris
PHVS
36 hedge funds and large institutions have $809M invested in Pharvaris in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
11% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 9
3% more funds holding
Funds holding: 35 → 36 (+1)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
18% less capital invested
Capital invested by funds: $980M → $809M (-$172M)
23.92% less ownership
Funds ownership: 103.83% → 79.91% (-24%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$11.3M |
| 2 |
DM
Deerfield Management
New York
|
+$6.83M |
| 3 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
+$5.19M |
| 4 |
CC
Commodore Capital
New York
|
+$1.73M |
| 5 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
+$699K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$4.99M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$4.55M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$3.51M |
| 4 |
Walleye Capital
New York
|
-$985K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$696K |
PHVS Hedge Fund Activity: Q2 2024 in Review
36 of the 6,927 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q2 2024, worth a combined $809M — down 18% from $980M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new PHVS positions and 4 closed out — a net gain of 1 holder — while 10 added to existing stakes and 9 trimmed.
The largest buyer was Novo Holdings A/S, adding an estimated $11.3M. The largest seller was Cormorant Asset Management, cutting an estimated $4.99M.
- 36 institutional investors held Pharvaris (PHVS) as of Q2 2024, up from 35 in Q1 2024.
- Funds reported $809M of Pharvaris stock for Q2 2024, down 18% quarter-over-quarter.
- 5 funds opened new Pharvaris positions in Q2 2024 and 4 closed out, a net change of +1 holder.
- The largest Pharvaris buyer in Q2 2024 was Novo Holdings A/S, an estimated $11.3M added.
- The largest Pharvaris seller in Q2 2024 was Cormorant Asset Management, an estimated $4.99M sold.
Based on aggregated 13F filings for Q2 2024.